Nordic Life Science
Nordic Life Science
The latest business news
The biopharmaceutical industry is in a frenzy to develop innovative drugs for cancer and no wonder, when the market size is estimated to be over 800 BNOK in 2020, the
Thank you Denmark! Seriously, on behalf of the Swedish life science industry organization, I mean it. Thank you for continuously keeping us on our toes, showing us and our politicians
Next week, on July 1st to July 8th, the Almedalen Week celebrates it’s 50th anniversary and life science will of course be on the agenda. Almedalen Week is an unusual
Xiaowei Zhuang’s microscopy method, STORM, has revolutionized life sciences and enabled breakthrough discoveries, and for this work she was awarded the Lennart Nilsson Award 2017. Xiaowei Zhuang, the David B. Arnold Professor of Science at Harvard University and a Howard Hughes Medical Institute Investigator, developed one of the first single-molecule imaging methods to break the diffraction limit, i.e. an optical effect that limits the resolution of conventional light microscopes to a few hundred
The capital of Sweden possesses not only world-renowned academic research and high profile life science companies, it is also home to many of the country’s most important national life science efforts and leading centers. The
Fermion Oy, which manufactures active pharmaceutical ingredients (APIs) for the global market, has entered the commissioning phase of its new plant in Hanko. The new manufacturing facility will replace the
Advertising
Drug & Device development
Oncopeptides present updated interim data from the ongoing HORIZON trial with Ygalo at the 23rd Congress of The European Hematology Association (EHA). The updated phase II-data show a clinical data
AstraZeneca and Eli Lilly and Company are discontinuing the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme (BACE) inhibitor, for the treatment of Alzheimer’s disease.
Follicum announces that all patients in the Phase IIa clinical trial with FOL-005 for stimulating hair growth have been recruited. The trial is conducted at the Clinical Research Center for
H. Lundbeck A/S and Takeda Pharmaceutical announce positive results from their pivotal study with vortioxetine in adults with Major Depressive Disorder conducted in Japan. Both companies intend to move forward
The US Food & Drug Administration has granted Fast Track designation to Betalutin (177Lu-lilotomab satetraxetan) for the treatment of patients with relapsed or refractory follicular lymphoma (FL) after at least
Lundbeck and Otsuka Pharmaceutical announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion on Rxulti (brexpiprazole) for
Shorten your study start-up time with PCG Clinical Services & Viedoc! 11 July 2018 by PCG Clinical Services
New development in the field of Liquid Handling: Highly viscous substances such as collagen are now pipettable 28 June 2018 by Eppendorf Nordic
We would like to thank our readers, subscribers and collaboration partners for a fruitful, eventful and fun Q1 + Q2 2018, and we wish you all a most wonderful summer!
Advertising
Latest news
Oncopeptides present updated interim data from the ongoing HORIZON trial with Ygalo at the 23rd Congress of The European Hematology Association (EHA). The updated phase II-data show a clinical data
Shorten your study start-up time with PCG Clinical Services & Viedoc! 11 July 2018 by PCG Clinical Services
New development in the field of Liquid Handling: Highly viscous substances such as collagen are now pipettable 28 June 2018 by Eppendorf Nordic
Our region is filled with life science activity. We take a closer look at what´s going in our Nordic cities when it comes to life science efforts, progress and challenges.
In focus – Nordic cities
Nordic Life Science
The latest clinical trials
Oncopeptides present updated interim data from the ongoing HORIZON trial with Ygalo at the 23rd Congress of The European Hematology Association (EHA). The updated phase II-data show a clinical data
AstraZeneca and Eli Lilly and Company are discontinuing the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme (BACE) inhibitor, for the treatment of Alzheimer’s disease.
Follicum announces that all patients in the Phase IIa clinical trial with FOL-005 for stimulating hair growth have been recruited. The trial is conducted at the Clinical Research Center for
H. Lundbeck A/S and Takeda Pharmaceutical announce positive results from their pivotal study with vortioxetine in adults with Major Depressive Disorder conducted in Japan. Both companies intend to move forward
Lundbeck and Otsuka Pharmaceutical announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion on Rxulti (brexpiprazole) for
The company has anounced results from PIONEER 2, the second phase 3a trial with oral semaglutide for treatment of adults with type 2 diabetes. Oral semaglutide is a new GLP-1
The two pharma giants reports data which showed clinical improvement in median radiologic progression-free survival (rPFS) with Lynparza (olaparib) in combination with abiraterone compared to abiraterone monotherapy, a standard of
The Phase 2b trial with Betalutin (177Lu-satetraxetan-lilotomab) in third-line (3L) follicular lymphoma (FL) patients has been approved by the Regional Committees for Medical and Health Research Ethics (REK) in Norway.
The trial, the second of two pivotal Phase III trials for Fasenra (benralizumab) in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), did not meet the primary endpoint of
The latest research findings from the Nordic region
Science Article
Xiaowei Zhuang’s microscopy method, STORM, has revolutionized life sciences and enabled breakthrough discoveries, and for this work she was awarded the Lennart Nilsson Award 2017. Xiaowei Zhuang, the David B. Arnold Professor of Science at Harvard University and a Howard Hughes Medical Institute Investigator, developed one of the first single-molecule imaging methods to break the diffraction limit, i.e. an optical effect that limits the resolution of conventional light microscopes to a few hundred
A new study from Karolinska Institutet and the University of Helsinki show that therapeutic use of gene editing with the CRISPR-Cas9 technique may inadvertently increase the risk of cancer. Two
A network for the promotion of research and education in microfluidics was recently launched at a conference at SciLifeLab. Microfluidics is a research area that deals with fluids on the
On May 28th international scientists and experts within outcomes research and patient centred healthcare gathered at the Karolinska Institute to discuss patient-driven development of pharmaceuticals, Swedish quality registers and their
High activity in a relatively poorly studied group of brain cells can be linked to aggressive behaviour in mice, a new study from Karolinska Institutet in Sweden shows. Using optogenetic
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. Genetic studies have linked